| P3780 |
active ingredient in |
... |
Q47521980 (Pepcid) |
Pepcid |
| P3780 |
active ingredient in |
... |
Q48829209 (Calmicid) |
Calmicid |
| P233 |
canonical SMILES |
String |
C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N |
??? |
| P373 |
Commons category |
String |
Famotidine |
??? |
| P1552 |
has characteristic |
... |
Q1517187 (bitterness) |
bitterness |
| P366 |
has use |
... |
Q12140 (medication) |
medication |
| P31 |
instance of |
... |
Q113145171 (type of chemical entity) |
type of chemical entity |
| P2017 |
isomeric SMILES |
String |
C1=C(N=C(S1)N=C(N)N)CSCC/C(=N/S(=O)(=O)N)/N |
??? |
| P8026 |
LiverTox likelihood score |
... |
Q83284310 (LiverTox toxicity likelihood category C) |
LiverTox toxicity likelihood category C |
| P2175 |
medical condition treated |
... |
Q187440 (urticaria) |
urticaria |
| P2175 |
medical condition treated |
... |
Q218712 (Zollinger–Ellison syndrome) |
Zollinger–Ellison syndrome |
| P2175 |
medical condition treated |
... |
Q223591 (gastroesophageal reflux disease) |
gastroesophageal reflux disease |
| P2175 |
medical condition treated |
... |
Q537297 (heartburn) |
heartburn |
| P2175 |
medical condition treated |
... |
Q653971 (indigestion) |
indigestion |
| P2175 |
medical condition treated |
... |
Q355170 (duodenal ulcer) |
duodenal ulcer |
| P2175 |
medical condition treated |
... |
Q2184368 (peptic esophagitis) |
peptic esophagitis |
| P2175 |
medical condition treated |
... |
Q4003020 (gastric ulcer) |
gastric ulcer |
| P2175 |
medical condition treated |
... |
Q26695607 (peripheral vascular disease) |
peripheral vascular disease |
| P3489 |
pregnancy category |
... |
Q3679232 (Australian pregnancy category B1) |
Australian pregnancy category B1 |
| P3489 |
pregnancy category |
... |
Q28123616 (US pregnancy category B) |
US pregnancy category B |
| P769 |
significant drug interaction |
... |
Q407883 (ketoconazole) |
ketoconazole |
| P769 |
significant drug interaction |
... |
Q906453 (posaconazole) |
posaconazole |
| P769 |
significant drug interaction |
... |
Q7157043 (pazopanib) |
pazopanib |
| P769 |
significant drug interaction |
... |
Q27139135 (dasatinib monohydrate) |
dasatinib monohydrate |
| P279 |
subclass of |
... |
Q409444 (H2 antagonists) |
H2 antagonists |
| P2868 |
subject has role |
... |
Q409444 (H2 antagonists) |
H2 antagonists |
| P2868 |
subject has role |
... |
Q41602594 (anti-ulcer drug) |
anti-ulcer drug |
| P2275 |
World Health Organisation international non-proprietary name |
Monolingualtext |
famotidine |
??? |
| P267 | ATC code | A02BA03 |
| P231 | CAS Registry Number | 76824-35-6 |
| P683 | ChEBI ID | 4975 |
| P592 | ChEMBL ID | CHEMBL902 |
| P661 | ChemSpider ID | 3208 |
| P9272 | DeCS ID | 24649 |
| P715 | DrugBank ID | DB00927 |
| P11198 | DrugCentral ID | 1129 |
| P8494 | DSSTOX compound identifier | DTXCID803039 |
| P3117 | DSSTox substance ID | DTXSID5023039 |
| P232 | EC number | 616-396-9 |
| P2566 | ECHA Substance Infocard ID | 100.116.793 |
| P1417 | Encyclopædia Britannica Online ID | topic/famotidine |
| P646 | Freebase ID | /m/035xrr |
| P595 | Guide to Pharmacology Ligand ID | 7074 |
| P2062 | HSDB ID | 3572 |
| P2057 | Human Metabolome Database ID | HMDB0001919 |
| P234 | InChI | InChI=1S/C8H15N7O2S3/c9-6(15-20(12,16)17)1-2-18-3-5-4-19-8(13-5)14-7(10)11/h4H,1-3H2,(H2,9,15)(H2,12,16,17)(H4,10,11,13,14) |
| P235 | InChIKey | XUFQPHANEAPEMJ-UHFFFAOYSA-N |
| P8408 | KBpedia ID | Famotidine |
| P665 | KEGG ID | D00318 |
| P7830 | LiverTox ID | Famotidine |
| P6689 | MassBank accession ID | MSBNK-LCSB-LU112101 |
| P6689 | MassBank accession ID | MSBNK-LCSB-LU112102 |
| P6689 | MassBank accession ID | MSBNK-LCSB-LU112103 |
| P6689 | MassBank accession ID | MSBNK-LCSB-LU112104 |
| P6689 | MassBank accession ID | MSBNK-LCSB-LU112105 |
| P6689 | MassBank accession ID | MSBNK-LCSB-LU112106 |
| P6689 | MassBank accession ID | MSBNK-LCSB-LU112151 |
| P6689 | MassBank accession ID | MSBNK-LCSB-LU112152 |
| P6689 | MassBank accession ID | MSBNK-LCSB-LU112153 |
| P6689 | MassBank accession ID | MSBNK-LCSB-LU112154 |
| P6689 | MassBank accession ID | MSBNK-LCSB-LU112155 |
| P6689 | MassBank accession ID | MSBNK-LCSB-LU112156 |
| P10245 | MedlinePlus drug identifier | a601142 |
| P10245 | MedlinePlus drug identifier | a687011 |
| P6694 | MeSH concept ID | M0024121 |
| P486 | MeSH descriptor ID | D015738 |
| P6680 | MeSH term ID | T046672 |
| P672 | MeSH tree code | D02.886.675.215 |
| P672 | MeSH tree code | D03.383.129.708.215 |
| P6366 | Microsoft Academic ID (discontinued) | 2781263782 |
| P2115 | NDF-RT ID | N0000146320 |
| P9405 | NMRShiftDB structure ID | 20211263 |
| P9405 | NMRShiftDB structure ID | 20207393 |
| P2840 | NSC number | 757810 |
| P10283 | OpenAlex ID | C2781263782 |
| P11199 | Probes And Drugs ID | PD001511 |
| P662 | PubChem CID | 3325 |
| P662 | PubChem CID | 5702160 |
| P662 | PubChem CID | 5353622 |
| P1579 | Reaxys registry number | 5767271 |
| P3345 | RxNorm CUI | 4278 |
| P4964 | SPLASH | splash10-0002-0090000000-2f572967a5007d2b7f7e |
| P4964 | SPLASH | splash10-000i-0029000000-087ab7a1109f0568738d |
| P4964 | SPLASH | splash10-000i-0900000000-e245f325e8c6f31a5fd0 |
| P4964 | SPLASH | splash10-001i-0090000000-f7866bb7df75274a328f |
| P4964 | SPLASH | splash10-014i-0090000000-368b33167f3ab7641ebd |
| P4964 | SPLASH | splash10-0a4i-0090000000-71071c8755b408328fbd |
| P4964 | SPLASH | splash10-0a4r-0950000000-0c16a77af1ba782fa15a |
| P4964 | SPLASH | splash10-0udi-0900000000-d8a9ef8fc58c0c705232 |
| P2877 | SureChEMBL ID | 973 |
| P2877 | SureChEMBL ID | 972 |
| P2877 | SureChEMBL ID | 39237 |
| P2892 | UMLS CUI | C0015620 |
| P11089 | UniChem compound ID | 514013 |
| P652 | UNII | 5QZO15J2Z8 |
| P11143 | WikiProjectMed ID | Famotidine |